Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

KZIAKZIA
2 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in KAZIA THERAPEUTICS LTD

Yes. BNP Paribas Financial Markets holds 30,090 shares of KZIA (Kazia Therapeutics), worth $423,667, as of its Q2 2026 13F filing. It increased the position from 1,081 shares in Q1 2026. BNP Paribas Financial Markets has held KZIA since Q1 2026, across 2 quarterly 13F filings.

Current Value

$423,667

Current Shares

30,090

Total Value Change

+$415,624

Total Shares Change

+29,009

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
30,090
+2683.5%
$423,6670.0%$14.08
39
2026-Q1
New
1,081
-
$8,0430.0%$7.44
25

Other major holders of KZIA: Alyeska Investment Group, L.P., Point72 Asset Management, L.P., Ensign Peak Advisors, Inc, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used